Pentostatin and Lenalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pentostatin (pentostatin) and Lenalidomide (lenalidomide). Common drug interactions include dizziness among females and device related infection among males.

The phase IV clinical study analyzes what interactions people have when they take Pentostatin and Lenalidomide. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Pentostatin?

Pentostatin has active ingredients of pentostatin. eHealthMe is studying from 833 Pentostatin users. Check the latest studies of Pentostatin.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 14, 2026

13 people who take Pentostatin and Lenalidomide together, and have interactions are studied.

Pentostatin and Lenalidomide drug interactions.

What are the common drug interactions of Pentostatin and Lenalidomide, by gender? *:

female:

Dizziness
Epistaxis (bleed from the nose)
Fatigue (feeling of tiredness)
Headache (pain in head)
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Pain

male:

Device related infection
Staphylococcal infection (an infection with staphylococcus bacteria)
Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)

What are the common drug interactions of Pentostatin and Lenalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)

40-49:

n/a

50-59:

n/a

60+:

Device related infection
Staphylococcal infection (an infection with staphylococcus bacteria)
Dizziness
Epistaxis (bleed from the nose)
Fatigue (feeling of tiredness)
Headache (pain in head)
Pain
Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 9 people, 69.23%
Richter's Syndrome (hairy cell cancer changes in fast growing b cell cancer tumour): 2 people, 15.38%
Neoplasm Malignant (cancer tumour): 1 person, 7.69%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 7.69%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Pentostatin and Lenalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously